These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9753232)

  • 1. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
    Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
    Murakami K; Okajima K; Harada N; Isobe H; Okabe H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of Gastric Mucosal Injury Model Animals of Rebamipide Formulation--Study of Therapeutic Equivalence].
    Abe N; Funato H; Hirata A; Nakai M; Iizuka M; Shiraishi H; Jobu K; Yagi Y; Kadota A; Ogi K; Yokota J; Miyamura M
    Yakugaku Zasshi; 2016; 136(4):677-84. PubMed ID: 27040349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.
    Gagliano-Jucá T; Moreno RA; Zaminelli T; Napolitano M; Magalhães AF; Carvalhaes A; Trevisan MS; Wallace JL; De Nucci G
    BMC Gastroenterol; 2016 Jun; 16(1):58. PubMed ID: 27259970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers.
    Kim HK; Kim JI; Kim JK; Han JY; Park SH; Choi KY; Chung IS
    Dig Dis Sci; 2007 Aug; 52(8):1776-82. PubMed ID: 17410467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat.
    Kim CD; Hong KW
    J Pharmacol Exp Ther; 1995 Oct; 275(1):340-4. PubMed ID: 7562569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.
    Hiratsuka T; Futagami S; Shindo T; Hamamoto T; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Shinoki K; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S84-9. PubMed ID: 16184426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rebamipide on lipid peroxidation and gastric mucosal injury induced by indometacin in rats.
    Yoshikawa T; Naito Y; Nakamura S; Nishimura S; Kaneko T; Iinuma S; Takahashi S; Kondo M; Yamasaki K
    Arzneimittelforschung; 1993 Dec; 43(12):1327-30. PubMed ID: 8141822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of escin against indomethacin-induced gastric ulcer in mice.
    Wang T; Zhao S; Wang Y; Yang Y; Yao L; Chu L; Du H; Fu F
    Toxicol Mech Methods; 2014 Dec; 24(8):560-6. PubMed ID: 25137224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of rebamipide against ammonia-induced gastric mucosal lesions.
    Takaishi O; Arakawa T; Yamasaki K; Fujiwara Y; Uchida T; Tominaga K; Watanabe T; Higuchi K; Fukuda T; Kobayashi K; Kuroki T
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):78S-82S. PubMed ID: 9753231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel.
    Tozawa K; Oshima T; Okugawa T; Ogawa T; Ohda Y; Tomita T; Hida N; Fukui H; Hori K; Watari J; Nakamura S; Miwa H
    Dig Dis Sci; 2014 Aug; 59(8):1885-90. PubMed ID: 24659236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antral ulcers induced by alendronate, a nitrogen-containing biphophonate, in rat stomachs - prophylactic effect of rebamipide.
    Ohashi Y; Aihara E; Takasuka H; Takahashi K; Takeuchi K
    J Physiol Pharmacol; 2009 Sep; 60(3):85-93. PubMed ID: 19826186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils.
    Sakurai K; Osaka T; Yamasaki K
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S90-6. PubMed ID: 16184427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells.
    Nagano Y; Matsui H; Muramatsu M; Shimokawa O; Shibahara T; Yanaka A; Nakahara A; Matsuzaki Y; Tanaka N; Nakamura Y
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S76-83. PubMed ID: 16184425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.
    Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S
    Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression.
    Naito Y; Kajikawa H; Mizushima K; Shimozawa M; Kuroda M; Katada K; Takagi T; Handa O; Kokura S; Ichikawa H; Yoshida N; Matsui H; Yoshikawa T
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S104-12. PubMed ID: 16184411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
    Niwa Y; Nakamura M; Ohmiya N; Maeda O; Ando T; Itoh A; Hirooka Y; Goto H
    J Gastroenterol; 2008; 43(4):270-6. PubMed ID: 18458842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
    Kim JH; Park SH; Cho CS; Lee ST; Yoo WH; Kim SK; Kang YM; Rew JS; Park YW; Lee SK; Lee YC; Park W; Lee DH
    Gut Liver; 2014 Jul; 8(4):371-9. PubMed ID: 25071901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
    Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide.
    Choi HS; Lim JY; Chun HJ; Lee M; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS; Sul D
    Life Sci; 2013 Jul; 93(2-3):69-77. PubMed ID: 23743168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.